PubRank

Y Morishima

Author PubWeight™ 156.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N Engl J Med 1998 3.62
2 Coordination of microtubules and the actin cytoskeleton by the Rho effector mDia1. Nat Cell Biol 2001 2.27
3 Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). Proc Natl Acad Sci U S A 1998 2.12
4 A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 1999 1.78
5 A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Kohseisho Leukemia Study Group. Blood 1994 1.73
6 Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood 1985 1.72
7 Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Eur Respir J 2001 1.65
8 Chaperoning of glucocorticoid receptors. Handb Exp Pharmacol 2006 1.62
9 Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood 2000 1.61
10 DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles. J Thromb Haemost 2008 1.60
11 Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients. Am J Surg Pathol 1999 1.55
12 Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 2001 1.54
13 Effect of intravenous omega-6 and omega-3 fat emulsions on nitrogen retention and protein kinetics in burned rats. Nutrition 1999 1.50
14 Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes. Immunogenetics 1984 1.43
15 Localization of a mammalian homolog of diaphanous, mDia1, to the mitotic spindle in HeLa cells. J Cell Sci 2001 1.33
16 Rapid determination of Epstein-Barr virus-specific CD8(+) T-cell frequencies by flow cytometry. Blood 1999 1.26
17 Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers. Oncogene 2012 1.25
18 Functionally different T lymphocyte subpopulations determined by their sensitivity to complement-dependent cell lysis with the monoclonal antibody 4A. J Immunol 1982 1.20
19 Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia. Leukemia 2010 1.19
20 Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001 1.17
21 Stoichiometry, abundance, and functional significance of the hsp90/hsp70-based multiprotein chaperone machinery in reticulocyte lysate. J Biol Chem 2001 1.15
22 CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. Blood 1997 1.11
23 CLCA1 gene polymorphisms in chronic obstructive pulmonary disease. J Med Genet 2004 1.10
24 Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505. Ann Oncol 2002 1.09
25 PBSC collection from family donors in Japan: a prospective survey. Bone Marrow Transplant 2013 1.09
26 hsp70 interacting protein Hip does not affect glucocorticoid receptor folding by the hsp90-based chaperone machinery except to oppose the effect of BAG-1. Biochemistry 2000 1.09
27 Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype. Blood 2000 1.08
28 Preliminary study of the role of red foxes in Echinococcus multilocularis transmission in the urban area of Sapporo, Japan. Parasitology 2000 1.08
29 Prediction of clinical relapse after bone-marrow transplantation by PCR for Philadelphia-positive acute lymphoblastic leukaemia. Lancet 1990 1.07
30 Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes. Leukemia 1999 1.07
31 Potential remedy against Echinococcus multilocularis in wild red foxes using baits with anthelmintic distributed around fox breeding dens in Hokkaido, Japan. Parasitology 2002 1.07
32 Selective usage of D-type cyclins in lymphoid malignancies. Leukemia 1999 1.05
33 Efficient cloning and expression of HLA class I cDNA in human B-lymphoblastoid cell lines. Tissue Antigens 2002 1.04
34 Prevalence of possible adult T-cell leukemia virus-carriers among volunteer blood donors in Japan: a nation-wide study. Int J Cancer 1984 1.01
35 Association of HLA-DR phenotypes and T-lymphocyte-receptor beta-chain-region RFLP with IDDM in Japanese. Diabetes 1988 1.01
36 API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products. Am J Pathol 2000 0.99
37 Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study Group. Ann Oncol 1998 0.99
38 Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression. Am J Surg Pathol 1997 0.98
39 Activation of the human transglutaminase 1 promoter in transgenic mice: terminal differentiation-specific expression of the TGM1-lacZ transgene in keratinized stratified squamous epithelia. Hum Mol Genet 1997 0.98
40 Functional and morphological differentiation induction of a human megakaryoblastic leukemia cell line (MEG-01s) by phorbol diesters. Blood 1988 0.98
41 Histaminergic axons in the neostriatum and cerebral cortex of the rat: a correlated light and electron microscopic immunocytochemical study using histidine decarboxylase as a marker. Brain Res 1986 0.97
42 Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis. Bone Marrow Transplant 2005 0.96
43 Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study. Ann Oncol 2002 0.96
44 Morphological spectrum of cyclin D1-positive mantle cell lymphoma: study of 168 cases. Pathol Int 2001 0.95
45 Re-treatment of relapsed indolent B-cell lymphoma with rituximab. Int J Hematol 2001 0.94
46 Interleukin-33 induces interleukin-17F in bronchial epithelial cells. Allergy 2012 0.93
47 Differential effects of the hsp70-binding protein BAG-1 on glucocorticoid receptor folding by the hsp90-based chaperone machinery. J Biol Chem 1999 0.92
48 Degradation of PEP-19, a calmodulin-binding protein, by calpain is implicated in neuronal cell death induced by intracellular Ca2+ overload. Neuroscience 2008 0.92
49 A single nucleotide polymorphism of IL-17 gene in the recipient is associated with acute GVHD after HLA-matched unrelated BMT. Bone Marrow Transplant 2011 0.92
50 Increases in collagen type I synthesis in asthma: the role of eosinophils and transforming growth factor-beta. Clin Exp Allergy 2002 0.91
51 Facilitated wound healing by activation of the Transglutaminase 1 gene. Am J Pathol 2000 0.91
52 Increased P-glycoprotein expression and multidrug-resistant gene (mdr1) amplification are infrequently found in fresh acute leukemia cells. Sequential analysis of 15 cases at initial presentation and relapsed stage. Cancer 1989 0.90
53 Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809. Ann Oncol 2010 0.89
54 Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2003 0.89
55 Effects of soybean oil emulsion and eicosapentaenoic acid on stress response and immune function after a severely stressful operation. Ann Surg 1999 0.89
56 16th IHIW: international histocompatibility working group in hematopoietic cell transplantation. Int J Immunogenet 2012 0.88
57 Impairment of cefdinir absorption by iron ion. Clin Pharmacol Ther 1993 0.88
58 Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry. Bone Marrow Transplant 2012 0.87
59 The HLA-A*0201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A*0206. Bone Marrow Transplant 2007 0.87
60 Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia. Bone Marrow Transplant 2013 0.86
61 A new polyvinylchloride blood bag plasticized with less-leachable phthalate ester analogue, di-n-decyl phthalate, for storage of platelets. Transfusion 1989 0.86
62 Hodgkin's disease expressing follicular dendritic cell marker CD21 without any other B-cell marker: a clinicopathologic study of nine cases. Am J Surg Pathol 1999 0.86
63 Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation. Bone Marrow Transplant 2013 0.86
64 Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantation. Bone Marrow Transplant 2006 0.86
65 Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome. Bone Marrow Transplant 2000 0.86
66 The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA-A*3101 and -A*3303. Br J Haematol 2006 0.86
67 Multiple polypoid lesions of primary mucosa-associated lymphoid-tissue lymphoma of colon. Histopathology 1998 0.86
68 Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia. Bone Marrow Transplant 1999 0.85
69 Carbohydrate differences in human high molecular weight antigens of B- and T-cell lines. Immunogenetics 1982 0.85
70 Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Ann Oncol 2013 0.85
71 Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation. Bone Marrow Transplant 2002 0.85
72 Growth inhibition of CD20-positive B lymphoma cell lines by IDEC-C2B8 anti-CD20 monoclonal antibody. Jpn J Cancer Res 1998 0.85
73 Hospital capacity and post-transplant survival after allogeneic bone marrow transplantation: analysis of data from the Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transplant 2000 0.85
74 Association of HLA antigen and restriction fragment length polymorphism of T cell receptor beta-chain gene with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab 1989 0.85
75 Detection of multidrug resistance markers, P-glycoprotein and mdr1 mRNA, in human leukemia cells. Jpn J Cancer Res 1987 0.84
76 Conserved CDR 3 region of T cell receptor BV gene in lymphocytes from bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis. Clin Exp Immunol 2002 0.84
77 Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma. Histopathology 2007 0.84
78 Trisomy 3 is a specific genomic aberration of t(14;18) negative follicular lymphoma. Leukemia 2007 0.84
79 Establishment of a follicular lymphoma cell line (FLK-1) dependent on follicular dendritic cell-like cell line HK. Leukemia 2001 0.84
80 Polymerase chain reaction (PCR)-based molecular discrimination between Paragonimus westermani and P. miyazakii at the metacercarial stage. Mol Cell Probes 2002 0.84
81 Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT). Bone Marrow Transplant 2013 0.84
82 Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Ann Oncol 2014 0.84
83 Dislocation of E-cadherin in the airway epithelium during an antigen-induced asthmatic response. Am J Respir Cell Mol Biol 2000 0.83
84 Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation. Bone Marrow Transplant 2006 0.83
85 Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in complete remission. Blood Cancer J 2013 0.83
86 Detection of Philadelphia chromosome-positive acute lymphoblastic leukemia by polymerase chain reaction: possible eradication of minimal residual disease by marrow transplantation. Blood 1992 0.83
87 Preoperative immunosuppression: its relationship with high morbidity and mortality in patients receiving thoracic esophagectomy. Nutrition 2001 0.83
88 First report of Trichinella nativa in red foxes (Vulpes vulpes schrencki) from Otaru City, Hokkaido, Japan. Parasitol Int 2001 0.81
89 Up-regulation of transferrin receptor gene expression by granulocyte colony-stimulating factor in human myeloid leukemia cells. Cancer Res 1990 0.81
90 A second record of adult Ascarops strongylina (Rudolphi, 1819) (Nematoda: Spirocercidae) in a rodent host. J Parasitol 1999 0.81
91 Association analysis of tissue inhibitor of metalloproteinase2 gene polymorphisms with COPD in Egyptians. Respir Med 2005 0.81
92 Clinical impact and predisposing factors of delayed-onset neutropenia after autologous hematopoietic stem-cell transplantation for B-cell non-Hodgkin lymphoma: association with an incremental risk of infectious events. Ann Oncol 2010 0.81
93 Molecular cytogenetic delineation of the breakpoint at 18q21.1 in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Genes Chromosomes Cancer 1999 0.81
94 Interleukin-1beta induces elevation of spermidine/spermine N1-acetyltransferase activity and an increase in the amount of putrescine in synovial adherent cells from patients with rheumatoid arthritis. J Rheumatol 2000 0.80
95 Long-term survival in acute leukemia in Japan. A study of 304 cases. Cancer 1980 0.80
96 Relationships between catecholaminergic neurons and cholecystokinin-containing neurons in the caudal part of the dorsomedial medulla oblongata of the rat: light and electron microscopic observations by the 'mirror technique'. Brain Res 1986 0.80
97 Biochemical characterization of human myeloperoxidase using three specific monoclonal antibodies. Br J Haematol 1986 0.80
98 Detection of adult T-cell leukemia virus (ATLV) bearing lymphocytes in concentrated red blood cells derived from ATL associated antibody (ATLA-Ab) positive donors. Vox Sang 1986 0.80
99 Increased risk for treatment-related mortality after bone marrow transplantation in GSTM1-positive recipients. Bone Marrow Transplant 2006 0.80
100 Hemorrhagic cystitis associated with urinary excretion of adenovirus type 11 following allogeneic bone marrow transplantation. Bone Marrow Transplant 1989 0.80
101 HapMap SNP Scanner: an online program to mine SNPs responsible for cell phenotype. Tissue Antigens 2012 0.80
102 Increased contribution by myofibrillar protein to whole-body protein breakdown according to severity of surgical stress. Nutrition 1996 0.80
103 Detection of AP12-MALT1 chimaeric gene in extranodal and nodal marginal zone B-cell lymphoma by reverse transcription polymerase chain reaction (PCR) and genomic long and accurate PCR analyses. Br J Haematol 2001 0.80
104 Cataloging of the genes expressed in human keratinocytes: analysis of 607 randomly isolated cDNA sequences. Biochem Biophys Res Commun 1994 0.79
105 Establishment of an IL-2-dependent cell line derived from 'nasal-type' NK/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virus. Br J Haematol 1998 0.79
106 Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors. Int J Hematol 1999 0.79
107 A novel human myeloid leukemia cell line, NKM-1, coexpressing granulocyte colony-stimulating factor receptors and macrophage colony-stimulating factor receptors. Cancer Res 1990 0.79
108 Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients. Blood 1993 0.79
109 Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor. Int J Hematol 1999 0.79
110 Activity of platelet-derived growth factor (PDGF) in platelet concentrates and cryopreserved platelets determined by PDGF bioassay. Vox Sang 1987 0.79
111 Ultrastructural observation of nerve fibers containing both substance P and calcitonin gene-related peptide in the nucleus tractus solitarii of the rat: a combination of immunofluorescence and PAP methods. Brain Res 1986 0.79
112 DX-9065a, an orally active factor Xa inhibitor, does not facilitate haemorrhage induced by tail transection or gastric ulcer at the effective doses in rat thrombosis model. Thromb Haemost 1999 0.79
113 Assessment of prognostic factors in follicular lymphoma patients. Int J Hematol 2001 0.79
114 Determination of the compositional distribution of copolymers by frontal analysis continuous capillary electrophoresis. Anal Chem 2000 0.79
115 Effect of radiation monitoring method and formula differences on estimated physician dose during percutaneous coronary intervention. Acta Radiol 2009 0.78
116 Syntheses and 5-HT2 antagonist activity of bicyclic 1,2,4-triazol-3(2H)-one and 1,3,5-triazine-2,4(3H)-dione derivatives. J Med Chem 1992 0.78
117 Overexpression of cyclin D1 in rat esophageal carcinogenesis model. Jpn J Cancer Res 1997 0.78
118 [Quantitative determination of lipoprotein by agarose gel electrophoresis and enzymatic staining of cholesterol and triglyceride: effects of age and gender]. Rinsho Byori 2001 0.78
119 Association of polymorphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated hematopoietic stem cell transplant donor/recipient pairs matched at five HLA loci. Tissue Antigens 2004 0.78
120 High-dose chemotherapy and autologous peripheral blood stem cell transfusion for adult and adolescent patients with small round cell sarcomas. Bone Marrow Transplant 2007 0.78
121 Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution in non-Hodgkin's lymphoma (NHL): results of Japanese phase II study. Bone Marrow Transplant 2005 0.78
122 The synaptic relationship between vasoactive intestinal polypeptide (VIP)-like immunoreactive neurons and their axon terminals in the rat small intestine: light and electron microscopic study. Brain Res 1985 0.78
123 Allogenic bone marrow transplantation as a treatment for adult T-cell leukemia. Int J Hematol 1999 0.78
124 Maintenance of the differentiated type II cell characteristics by culture on an acellular human amnion membrane. In Vitro Cell Dev Biol Anim 2001 0.78
125 Early molecular and cellular events of oxidant-induced pulmonary fibrosis in rats. Toxicol Appl Pharmacol 2000 0.78
126 Exposure to diesel exhaust exacerbates allergen-induced airway responses in guinea pigs. Am J Respir Crit Care Med 2001 0.78
127 No substantial difference in genotype frequencies of interleukin and myeloperoxidase polymorphisms between malignant lymphoma patients and non-cancer controls. Haematologica 2001 0.78
128 Effects of intravenous omega-3 and omega-6 fat emulsion on cytokine production and delayed type hypersensitivity in burned rats receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr 1999 0.78
129 Analysis of 55 transplantations from unrelated volunteer donors facilitated by Tokai Marrow Donor Bank. Intern Med 1996 0.78
130 Analysis of immunophenotype, genotype, and lineage fidelity in blastic transformation of chronic myelogenous leukemia: a study of 20 cases. J Lab Clin Med 1988 0.78
131 Inhibition of farnesyl protein transferase by monoterpene, curcumin derivatives and gallotannin. Anticancer Res 1997 0.78
132 Behenoyl cytosine arabinoside, daunorubicin, 6-mercaptopurine, and prednisolone combination therapy for acute myelogenous leukemia in adults and prognostic factors related to remission duration and survival length. J Clin Oncol 1986 0.78
133 Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study Group. Cancer Chemother Pharmacol 1997 0.77
134 Synaptic interaction between catecholaminergic neurons and substance P-immunoreactive axons in the caudal part of the nucleus of the solitary tract of the rat: demonstration by the electron microscopic mirror technique. Brain Res 1985 0.77
135 Phase I and pharmacokinetic study of oral fludarabine phosphate in relapsed indolent B-cell non-Hodgkin's lymphoma. Ann Oncol 2005 0.77
136 Blockade of cysteinyl leukotriene-1 receptors suppresses airway remodelling in mice overexpressing GATA-3. Clin Exp Allergy 2011 0.77
137 Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitor. Thromb Res 1995 0.77
138 Quality of life in adult patients after stem cell transplantation. Int J Hematol 2000 0.77
139 A single-nucleotide polymorphism of the Fcγ receptor type IIIA gene in the recipient predicts transplant outcomes after HLA fully matched unrelated BMT for myeloid malignancies. Bone Marrow Transplant 2010 0.77
140 Somatic hypermutations in the VH segment of immunoglobulin genes of CD5-positive diffuse large B-cell lymphomas. Jpn J Cancer Res 1997 0.77
141 Generation and characterization of lymphokine-activated killer cells against fresh human leukemia cells. Jpn J Cancer Res 1988 0.77
142 Rapid serum vancomycin assay by high-performance liquid chromatography using a semipermeable surface packing material column. Clin Chim Acta 2000 0.77
143 Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR. Bone Marrow Transplant 2012 0.77
144 A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia. The Kouseisho Leukemia Study Group. Leuk Res 1998 0.77
145 Local T cell subsets in mumps meningitis. Arch Dis Child 1983 0.77
146 Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: indications and dose escalation. Ther Apher 2001 0.77
147 Adenovirus-induced late onset hemorrhagic cystitis following allogeneic bone marrow transplantation. Bone Marrow Transplant 1987 0.77
148 Immunohistochemical detection of meconium in the fetal membrane, placenta and umbilical cord. Placenta 2011 0.77
149 Influence of cardiac output on the pseudo-steady state remifentanil and propofol concentrations in swine. Acta Anaesthesiol Scand 2013 0.77
150 Complete cytogenetic response with host-derived hematopoiesis induced by cyclosporin A discontinuation in a patient with relapsed chronic myelogenous leukemia after bone marrow transplantation. Bone Marrow Transplant 1997 0.76
151 Retroviral vector backbone immunogenicity: identification of cytotoxic T-cell epitopes in retroviral vector-packaging sequences. Gene Ther 2005 0.76
152 Catabolism of lipoprotein-X induced by infusion of 10% fat emulsion. Nutrition 1997 0.76
153 Polymorphisms in the coding region of mtDNA and effects on clinical outcome of unrelated bone marrow transplantation. Bone Marrow Transplant 2001 0.76
154 Treatment of adult T cell leukemia with mega-dose cyclophosphamide and total body irradiation followed by allogeneic bone marrow transplantation. Bone Marrow Transplant 1987 0.76
155 Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transplant 2013 0.76
156 Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas. Leukemia 2011 0.76
157 Infrequent BCL10 mutations in B-cell non-Hodgkin's lymphomas. Jpn J Cancer Res 1999 0.76
158 A case of infantile acute monocytic leukemia caused by vertical transmission of the mother's leukemic cells. Cancer 1990 0.76
159 Enhanced expression of DNA topoisomerase II by recombinant human granulocyte colony-stimulating factor in human leukemia cells. Cancer Res 1990 0.76
160 DY-9760e, a novel calmodulin antagonist, reduces brain damage induced by transient focal cerebral ischemia. Eur J Pharmacol 1999 0.76
161 Treatment of plasma cell neoplasm with recombinant leukocyte A interferon and human lymphoblastoid interferon. Cancer Chemother Pharmacol 1985 0.75
162 Effect of severity of stress on whole-body protein kinetics in surgical patients receiving parenteral nutrition. Nutrition 1997 0.75
163 Attribution of posttransplantation toxicity to methotrexate regarding genotype of methylenetetrahydrofolate reductase gene (MTHFR) polymorphism needs further clarification. Blood 2001 0.75
164 Immunological studies on adult T cell leukaemia virus (ATLV) carriers. Clin Exp Immunol 1986 0.75
165 Dystrophic axons in the nucleus gracilis of the normal rat containing cholecystokinin-like immunoreactivity. Light- and electron-microscopic observations. Acta Neuropathol 1985 0.75
166 DY-9760e, a novel calmodulin antagonist with cytoprotective action. Eur J Pharmacol 1997 0.75
167 Detection of cross-reactive antibody to BLV p24 in sera of human patients infected with HTLV. Microbiol Immunol 1987 0.75
168 Treatment of acute myeloid leukemia. N Engl J Med 1999 0.75
169 Acute lymphoblastic leukaemia of the B-cell type refractory to intensive chemotherapy. Clin Exp Immunol 1978 0.75
170 [Immunohistochemical study on regional lymph nodes of gastric cancer]. Nihon Shokakibyo Gakkai Zasshi 1987 0.75
171 [The current status and the future prospect to the bio-clean room]. Kango Gijutsu 1978 0.75
172 Lack of a kinetic interaction between fluconazole and mexiletine. Eur J Clin Pharmacol 1996 0.75
173 Combined effect of the 5-HT2 receptor antagonist DV-7028 and aspirin or heparin on coronary cyclic flow reductions in dogs. Cardiovasc Res 1993 0.75
174 Capillary zone electrophoresis of albumin-depleted human serum using a linear polyacrylamide-coated capillary: separation of serum alpha-and beta-globulins into individual components. Electrophoresis 2000 0.75
175 Anomalous expression of histocompatibility antigens on human leukemia cells. Nihon Ketsueki Gakkai Zasshi 1981 0.75
176 Analysis of two new leukemia-associated antigens detected on human T-cell acute lymphoblastic leukemia using monoclonal antibodies. Blood 1983 0.75
177 [Treatment of infection in the patients of acute leukemia with sulfamethoxazole-trimethoprim (author's transl)]. Rinsho Ketsueki 1979 0.75
178 Strategies for typing new volunteer donors. Tissue Antigens 2007 0.75
179 [Unrelated bone marrow transplantation b. Bone Marrow Donor Registry. Nagoya Bone Marrow Transplantation Group]. Rinsho Ketsueki 1990 0.75
180 A clinical trial of cell-wall skeleton of BCG in chemoimmunotherapy of acute leukemia. Gan 1978 0.75
181 Bone marrow transplantation in 614 patients: twenty year experience of the Nagoya Bone Marrow Transplantation Group (NBMTG). Transplant Proc 1995 0.75
182 [Prognostic factors related to remission duration and the effects of maintenance therapy in BHAC-DMP therapy in adult acute non-lymphocytic leukemia patients]. Rinsho Ketsueki 1986 0.75
183 [The bone marrow transplantation in interstitial pneumonia]. Rinsho Ketsueki 1982 0.75
184 Solubilization and characterization of substance P binding protein from bovine brainstem. J Neurochem 1988 0.75
185 Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study. Bone Marrow Transplant 2008 0.75
186 [Clinical analysis of adult acute leukemia without successful induction of remission]. Rinsho Ketsueki 1983 0.75
187 [N-3 polyunsaturated fatty acids in surgical nutrition]. Nihon Geka Gakkai Zasshi 1998 0.75
188 A recurrent keratin 14 mutation in Dowling-Meara epidermolysis bullosa simplex. Br J Dermatol 1999 0.75
189 Randomized comparison of mobilization kinetics of circulating CD34+ cells between biweekly CHOP and dose-escalated CHOP with the prophylactic use of lenograstim (glycosylated rHuG-CSF) in aggressive non-Hodgkin's lymphoma. The lenograstim/Lymphoma Study Group. Leuk Lymphoma 2000 0.75
190 Inverse association between soy intake and non-Hodgkin lymphoma risk among women: a case-control study in Japan. Ann Oncol 2011 0.75
191 [New therapeutic strategy for malignant lymphoma targeting cell surface antigens]. Rinsho Ketsueki 1999 0.75
192 Clinical characteristics of chronic cutaneous graft-versus-host disease in Japanese leukemia patients after bone marrow transplantation: low incidence and mild manifestations of skin lesions. Bone Marrow Transplant 1992 0.75
193 Method for processing leukocyte- and platelet-poor red cells in closed bags. Vox Sang 1986 0.75
194 Bone marrow transplantation for chronic myelogenous leukemia in blastic phase using a phenotypically identical unrelated volunteer donor. Nagoya Bone Marrow Transplantation Group (NBMTG), Tokai Marrow Donor Bank (TMDB). Int J Hematol 1992 0.75
195 [Use of cyclosporin A in 5 leukemia patients receiving allogeneic bone marrow transplantation]. Rinsho Ketsueki 1984 0.75
196 [Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia]. Rinsho Ketsueki 1991 0.75
197 Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG). Leukemia 1992 0.75
198 [Treatment of therapy-resistant acute non-lymphocytic leukemia with PADOC (author's transl)]. Rinsho Ketsueki 1978 0.75
199 One-stage thoracic aortic aneurysm treatment and coronary artery bypass grafting. Jpn J Thorac Cardiovasc Surg 2001 0.75
200 Pharmacological profile of a new 5-hydroxytryptamine2 receptor antagonist, DV-7028. Arch Int Pharmacodyn Ther 1993 0.75
201 The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis. Bone Marrow Transplant 2013 0.75
202 Delineation of the breakpoint at 18q21.1 in a cell line (Karpas1106) derived from mediastinal B-cell lymphoma by fluorescence in situ hybridization with multiple YAC clones. Int J Cancer 1998 0.75
203 Induction of apoptosis in CTLL-2 cells by protocatechualdehyde. Anticancer Res 2001 0.75
204 Ebselen decreases ozone-induced pulmonary inflammation in rats. Lung 2000 0.75
205 [Monoclonal antibody and purging]. Gan No Rinsho 1989 0.75
206 Biological potency of a fluorinated vitamin D analogue in hypoparathyroidism. Bone Miner 1992 0.75
207 [Studies of tumor specific antigens on leukemic cells by mixed lymphocyte-leukemic cell cultures (author's transl)]?9H. Nihon Ketsueki Gakkai Zasshi 1977 0.75
208 [Coordination of unrelated bone marrow donors in the Tokai Bone Marrow Bank--psychological reactions of donors to donation]. Rinsho Ketsueki 1994 0.75
209 The importance of warming at 37 degrees C for removal of leukocytes and platelets from reconstituted red cells. Transfusion 1984 0.75
210 [Second syngeneic bone marrow transplantation in a case of erythroleukemia (author's transl)]. Rinsho Ketsueki 1978 0.75
211 CD34+-selected autologous peripheral blood stem cell transplantation conditioned with total body irradiation for malignant lymphoma: increased risk of infectious complications. Int J Hematol 2001 0.75
212 Determination of low affinity platelet factor 4 in frozen and thawed human platelets by the newly developed enzyme immunoassay system. Tohoku J Exp Med 1984 0.75
213 Allogeneic bone marrow transplantation in 25 patients with severe aplastic anemia. Nihon Ketsueki Gakkai Zasshi 1988 0.75
214 Human monoclonal antibodies to human cytomegalovirus derived from peripheral blood lymphocytes of healthy adults. J Med Virol 1990 0.75
215 Influence of pretransplant clinical conditions on the prognosis of patients treated with allogeneic bone marrow transplantation during leukemia relapse. Nihon Ketsueki Gakkai Zasshi 1986 0.75
216 [Bone marrow transplantation from a phenotypically identical mother in a patient with acute lymphoblastic leukemia]. Rinsho Ketsueki 1985 0.75
217 Light and electron microscopic studies of calcitonin gene-related peptide-like immunoreactive neurons and axon terminals of the nucleus of the tractus solitarius of the rat. Brain Res 1985 0.75
218 [Bone marrow transplantation in cancer patients]. Gan To Kagaku Ryoho 1986 0.75
219 [Surgical results of valvular heart disease combined with myocardial revascularization]. Kyobu Geka 2000 0.75
220 [Treatment of adult acute promyelocytic leukemia during the period of 1974-1982]. Rinsho Ketsueki 1984 0.75
221 A dose-finding study of lenograstim (glycosylated rHuG-CSF) for peripheral blood stem cell mobilization during postoperative adjuvant chemotherapy in patients with breast cancer. Lenograstim/Breast Cancer Study Group. Jpn J Clin Oncol 1999 0.75
222 [Septicemia in patients with acute leukemia and result of its treatment (author's transl)]. Nihon Naika Gakkai Zasshi 1978 0.75
223 [Fungal infection in leukemic patients at autopsy (author's transl)]. Rinsho Ketsueki 1977 0.75
224 [Clinical efficacy of YNK 01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate) in patients with polycythemia vera]. Gan To Kagaku Ryoho 1993 0.75
225 [Laboratory and clinical studies on imipenem/cilastatin sodium plus amikacin sulfate in patients with severe infections complicating hematological disorders]. Jpn J Antibiot 1991 0.75
226 [A case of acute lymphoblastic leukemia treated with allogeneic bone marrow transplantation from a HLA identical sibling (author's transl)]. Rinsho Ketsueki 1978 0.75
227 Cytotoxic large T-cell lymphoma with fulminant clinical course, CD8+ and CD56- phenotype, and its relation to Epstein-Barr virus: a report of two cases. Int J Hematol 1999 0.75
228 Effective and safe interferon treatment for Japanese patients with chronic myelogenous leukemia relapse after bone marrow transplantation. The Nagoya Blood and Marrow Transplantation Group. Int J Hematol 2000 0.75
229 A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34(+)-selection method in cyclin D1(+)-mantle cell lymphoma. Int J Hematol 1998 0.75
230 Inhibition by nitroglycerin of canine platelet aggregation and cyclic flow reductions in stenosed coronary arteries. Methods Find Exp Clin Pharmacol 1995 0.75
231 Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation. Nagoya BMT Group. Bone Marrow Transplant 1999 0.75
232 Expression of H-related antigen on human megakaryocytes and megakaryocytic leukemia cells. Int J Hematol 1991 0.75
233 [Study of chronic graft-vs-host disease, infection and immune reconstitution in patients surviving more than one year after bone marrow transplantation from unrelated donors]. Rinsho Ketsueki 1999 0.75
234 Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia. Jpn J Cancer Res 1985 0.75
235 [Successful bone marrow transplantation in a case of severe aplastic anemia refractory to platelet transfusions]. Rinsho Ketsueki 1987 0.75
236 Platelet factor 4 release from the platelets stored in platelet concentrates. Transfusion 1985 0.75
237 [4 cases of B-cell type acute lymphatic leukemia resistant to chemotherapy]. Nihon Rinsho 1978 0.75
238 Serum thrombopoietin level after allogeneic bone marrow transplantation: possible correlations with platelet recovery, acute graft-versus-host disease and hepatic veno-occlusive disease. Nagoya Bone Marrow Transplantation Group. Int J Hematol 1996 0.75
239 [Donor coordination at bone marrow banks and the role of coordinators]. Nihon Naika Gakkai Zasshi 1998 0.75
240 Genotyping analysis of HLA-class II and III genes in unrelated bone marrow transplantation among Japanese. Nagoya Bone Marrow Transplantation Group and Tokai Marrow Donor Bank. Transplant Proc 1995 0.75
241 Diversity of acute non-lymphocytic leukemia analyzed with monoclonal antibodies reactive with myeloid differentiation antigens. Jpn J Clin Oncol 1986 0.75
242 Disease stage stratified effects of cell dose in unrelated BMT for hematological malignancies: a report from Japan Marrow Donor Program. Bone Marrow Transplant 2010 0.75
243 [Combination chemotherapy with vincristine, cyclophosphamide, procarbazine and prednisolone in advanced reticulum cell sarcoma (author's transl)]. Rinsho Ketsueki 1976 0.75
244 New closed system using a sterile connection device and preconnected PRP pack for extended storage of apheresis platelet products. Tohoku J Exp Med 1988 0.75
245 Hemodynamic effects of lipo-PGE1 on peripheral artery in patients with diabetic neuropathy: evaluated by two-dimensional color Doppler echography. Diabetes Res 1993 0.75
246 Human platelet alloantigen (HPA)-5a/b mismatch decreases disease-free survival in unrelated bone marrow transplantation. Tissue Antigens 1999 0.75
247 Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia. Haematol Blood Transfus 1990 0.75
248 Effects of insulin-like growth factor-1 on endotoxin translocation in burned rats receiving total parenteral nutrition. Nutrition 1997 0.75
249 Cardiac operations in patients with severe pulmonary impairment. Ann Thorac Cardiovasc Surg 2000 0.75
250 [Results of allogeneic bone marrow transplantation in leukemia]. Rinsho Ketsueki 1985 0.75
251 [Characteristics of blood cells during peripheral blood stem cell mobilization following chemotherapy in patients with non-Hodgkin's lymphoma]. Rinsho Ketsueki 2000 0.75
252 [DCTP and DCMP two step therapy in acute non-lymphocytic leukemia (author's transl)]. Rinsho Ketsueki 1980 0.75
253 Occupational contact urticaria syndrome from cefotiam dihydrochloride in a latex-allergic nurse. Contact Dermatitis 2000 0.75
254 [Interstitial pneumonia (IP) in bone marrow transplantation in leukemia--120 cases analysis in Nagoya Bone Marrow Transplantation Group]. Rinsho Ketsueki 1989 0.75
255 [A case of posthepatitic severe aplastic anemia treated with allogeneic bone marrow transplantation (author's transl)]. Rinsho Ketsueki 1979 0.75
256 Studies of leukemia specific antigen and immunotherapy of acute leukemia with cell-wall skeleton of BCG. Nihon Ketsueki Gakkai Zasshi 1978 0.75
257 Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia. Jpn J Cancer Res 1985 0.75
258 Sixteen adult patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation. Jpn J Clin Oncol 1984 0.75
259 Bone marrow transplantation for acute leukemia and aplastic anemia. Nihon Ketsueki Gakkai Zasshi 1977 0.75
260 [Clinical courses of 13 cases of long-term survivors after allogeneic bone marrow transplantation]. Rinsho Ketsueki 1987 0.75
261 [Four cases with congenital factor XII (Hageman factor) deficiency (author's transl)]. Rinsho Ketsueki 1977 0.75
262 An in vitro evaluation of leukocyte-poor red blood cell concentrates prepared by reconstitution with phosphate buffer solution. Tohoku J Exp Med 1983 0.75
263 [Present status of donor leukocyte transfusion for leukemia. Relapse after allogeneic bone marrow transplantation in Japan]. Rinsho Ketsueki 1997 0.75
264 [Bone marrow transplantation from donors other than HLA matched siblings for hematological malignancies. Nagoya Bone Marrow Transplantation Group and Tokai Marrow Donor Bank]. Rinsho Ketsueki 1994 0.75
265 [Allogeneic bone marrow transplantation in 14 cases of leukemia]. Nihon Ketsueki Gakkai Zasshi 1982 0.75
266 A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial. Int J Hematol 1999 0.75
267 [Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)]. Gan To Kagaku Ryoho 1984 0.75
268 [L-Asparaginase therapy in chemotherapy-resistant acute lymphocytic leukemias (author's transl)]. Rinsho Ketsueki 1979 0.75
269 Gamma-interferon production capacity and T lymphocyte subpopulation after allogeneic bone marrow transplantation. Transplantation 1986 0.75
270 New xenografts of human megakaryoblastic cell line (MEG-01) for evaluating anti-tumor agents. Leukemia 1993 0.75
271 [Cancer curable by chemotherapy: acute myelogenous leukemia]. Gan To Kagaku Ryoho 1989 0.75
272 [Clinical features of adult patients with acute lymphocytic leukemia according to immunological phenotypes of lymphoblasts (author's transl)]. Nihon Ketsueki Gakkai Zasshi 1979 0.75
273 Epidermolysis bullosa acquisita: correlation of IgE levels with disease activity under successful betamethasone/dapsone combination therapy. Acta Derm Venereol 2002 0.75
274 [Allogeneic bone marrow transplantation in 91 patients with acute leukemia (Nagoya Bone Marrow Transplantation Group)]. Rinsho Ketsueki 1988 0.75
275 Influence of haemorrhage on the pseudo-steady-state remifentanil concentration in a swine model: a comparison with propofol and the effect of haemorrhagic shock stage. Br J Anaesth 2011 0.75
276 Do the kidneys contribute to propofol elimination? Br J Anaesth 2008 0.75
277 Establishment and characterization of a new human Bence Jones-type myeloma cell line, NOP-2. Int J Hematol 1991 0.75
278 Effect of IGF-1 on protein metabolism in burned rats. JPEN J Parenter Enteral Nutr 1999 0.75
279 Absence of demonstrable suppressor cell activity in a severe combined immunodeficiency patient with a sustained engraftment of DR-positive maternal T cells. Transplant Proc 1981 0.75
280 [Outcomes of 50 leukemia patients who received bone marrow transplants from unrelated donors]. Rinsho Ketsueki 1998 0.75
281 [Bone marrow transplantation]. Rinsho Byori 1991 0.75
282 Pharmacologic and clinical studies of N4-behenoyl-1-beta-D-arabinofuranosylcytosine. Recent Results Cancer Res 1980 0.75
283 Use of cyclophosphamide and total lymphoid irradiation combined with cyclosporine in bone marrow transplantation for transfused severe aplastic anemia. Bone Marrow Transplant 1988 0.75
284 [Hematological studies in patients with anorexia nervosa (author's transl)]. Rinsho Ketsueki 1978 0.75
285 Long-term results of root reconstruction using the Carrel patch. Jpn J Thorac Cardiovasc Surg 2000 0.75
286 Screening of blood donors for antibody to human immunodeficiency virus type I by sensitive particle agglutination assay. Vox Sang 1988 0.75
287 [A preliminary analysis of unrelated marrow transplantations facilitated by the Japan Marrow Donor Program (JMDP)]. Rinsho Ketsueki 1995 0.75
288 [Efficacy of granisetron, a 5-HT3 antagonist, in the prevention of nausea and vomiting induced by conditioning for hematopoietic stem cell transplantation]. Rinsho Ketsueki 1998 0.75